TY - JOUR
TI - Cemiplimab for cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
VL - 45
IS - 4
SP - 136
EP - 137
DO - 10.18773/austprescr.2022.050
LA - eng
UR - https://australianprescriber.tg.org.au/articles/cemiplimab-for-cutaneous-squamous-cell-carcinoma-basal-cell-carcinoma-non-small-cell-lung-cancer.html
KW - basal cell carcinoma
KW - cemiplimab
KW - cutaneouos squamous cell carcinoma
KW - Libtayo
KW - non-small cell lung cancer
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -